Findings

What do systematic reviews say?

281 questions · 293 findings · 19 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 72 · 24.6%GRADE not reported 38 · 13%Very low 60 · 20.5%Low 94 · 32.1%Moderate 29 · 9.9%High 0 · 0%

NaoXinTong vs 'no treatment'

Behaviour ‐ not measured · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

YinDanXingNaoTong vs 'no treatment'

Cognitive function · People with vascular dementia

2 findings from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 139 participants
Low
Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

YinDanXingNaoTong vs 'no treatment'

Cognition‐ADAS‐Cog ‐ not measured · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

YinDanXingNaoTong vs 'no treatment'

Global performance (improved) ‐ not measured · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

YinDanXingNaoTong vs 'no treatment'

Adverse events (AEs) (1 or more events) · People with vascular dementia

YinDanXingNaoTong showed no clear difference in adverse events (AEs) (1 or more events) compared with 'no treatment' (low certainty).

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
RD 0
2 studies · 138 participants
Low

YinDanXingNaoTong vs 'no treatment'

Activities of daily living · People with vascular dementia

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 139 participants
Moderate

YinDanXingNaoTong vs 'no treatment'

Behaviour ‐ not measured · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

FuFangDanShen vs 'no treatment'

Cognition‐ADAS‐Cog · People with vascular dementia

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 321 participants
Moderate

FuFangDanShen vs 'no treatment'

Global performance (improved) ‐ not measured · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

FuFangDanShen vs 'no treatment'

Adverse events (AEs) (1 or more events) · People with vascular dementia

FuFangDanShen showed no clear difference in adverse events (AEs) (1 or more) compared with 'no treatment' (low certainty).

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
RD 0.02
3 studies · 322 participants
Low

FuFangDanShen vs 'no treatment'

Activities of daily living · People with vascular dementia

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 95 participants
Moderate

FuFangDanShen vs 'no treatment'

Behaviour ‐ not measured · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

FuFangHaiShe vs 'no treatment'

Cognitive function · People with vascular dementia

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 110 participants
Low

FuFangHaiShe vs 'no treatment'

Cognition‐HDS ‐ not measured · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

WENDAN DECOCTION vs placebo or no treatment

Global state: Clinically important change ‐ no improvement ‐ defined as PANSS < 50% reduction (short term) · patients with schizophrenia

WENDAN DECOCTION may leads to lower global state: Clinically important change ‐ no improvement ‐ defined… compared with PLACEBO OR NO TREATMENT (low certainty).

1 finding from 1 review

Wendan decoction (Traditional Chinese medicine) for schizophrenia 2017 · Cochrane Headline outcomes only
RR 0.53 [0.39, 0.73]
1 study · 72 participants
Low

WENDAN DECOCTION vs antipsychotics

Adverse effects: any observed extrapyramidal symptoms ‐ short term (up to 6 months) · patients with schizophrenia

WENDAN DECOCTION probably leads to lower adverse effects: Movement disorders ‐ Extra Pyramidal Symptoms… compared with ANTIPSYCHOTIC DRUG (moderate certainty).

1 finding from 1 review

Wendan decoction (Traditional Chinese medicine) for schizophrenia 2017 · Cochrane Headline outcomes only
RR 0.02 [0, 0.15]
2 studies · 140 participants
Moderate

WENDAN DECOCTION vs antipsychotics

Adverse effects: Metabolic ‐ weight change (medium term) · patients with schizophrenia

1 finding from 1 review

Wendan decoction (Traditional Chinese medicine) for schizophrenia 2017 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

WENDAN DECOCTION vs antipsychotics

Quality of life/satisfaction with care: Clinically important change in quality of life/satisfaction, as defined by each study (medium term) · patients with schizophrenia

1 finding from 1 review

Wendan decoction (Traditional Chinese medicine) for schizophrenia 2017 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

WENDAN DECOCTION vs antipsychotics

Economic outcomes: Costs due to treatment, as defined by each study (long term) · patients with schizophrenia

1 finding from 1 review

Wendan decoction (Traditional Chinese medicine) for schizophrenia 2017 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

WENDAN DECOCTION PLUS NORMAL DOSE ANTIPSYCHOTIC vs STANDARD DOSE ANTIPSYCHOTICS

Global state: Clinically important change ‐ no improvement ‐ defined as PANSS < 50% reduction (short term) · patients with schizophrenia

WENDAN DECOCTION PLUS NORMAL DOSE ANTIPSYCHOTIC probably leads to lower global state: Clinically important change ‐ no improvement ‐ defined… compared with NORMAL DOSE ANTIPSYCHOTIC (moderate certainty).

1 finding from 1 review

Wendan decoction (Traditional Chinese medicine) for schizophrenia 2017 · Cochrane Headline outcomes only
RR 0.6 [0.5, 0.72]
6 studies · 684 participants
Moderate